ALISO VIEJO, Calif., Sept. 29, 2011 / PRNewswire/ --Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
No comments:
Post a Comment